A case-control study on correlation between the single nucleotide polymorphism of CLEC4E and the susceptibility to tuberculosis among Han people in Western China.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
10 Aug 2021
Historique:
received: 29 09 2020
accepted: 20 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 25 9 2021
Statut: epublish

Résumé

Tuberculosis (TB) is one of the leading causes of morbidity and mortality in Western China. Preclinical studies have suggested the protective effect of the C-type lectin receptor of family 4 member E (CLEC4E) from TB. Herein, we investigated the association between CLEC4E gene variants and TB susceptibility in a western Chinese Han population. We genotyped four single nucleotide polymorphisms (SNPs) rs10841856, rs10770847, rs10770855 and rs4480590 in the CLEC4E gene using the improved multiplex ligation detection reaction (iMLDR) assay in 900 TB cases and 1534 healthy controls. After stratifying the whole data by sex, it was found that males exhibited mutant allele G of rs10841856 was more strongly associated with increased TB risk after Bonferroni correction (OR = 1.334, 95% CI: 1.142-1.560; P < 0.001 after adjusting for age; p = 0.001 after Bonferroni correction). The genetic model analysis found that rs10841856 was associated with the increased risk of TB among males under the dominant model (OR = 1.557, 95% CI = 1.228-1.984, P < 0.001 after adjusting for age, P < 0.001 after Bonferroni correction). Bioinformatics analysis suggested that rs10841856 might fall in putative functional regions and might be the expression quantitative trait loci (eQTL) for CLEC4E and long noncoding RNA RP11-561P12.5. Our study revealed that rs10841856 in the CLEC4E gene might be related to increased TB risk, especially the dominant genetic model among male Han individuals from Western China.

Sections du résumé

BACKGROUND BACKGROUND
Tuberculosis (TB) is one of the leading causes of morbidity and mortality in Western China. Preclinical studies have suggested the protective effect of the C-type lectin receptor of family 4 member E (CLEC4E) from TB. Herein, we investigated the association between CLEC4E gene variants and TB susceptibility in a western Chinese Han population.
METHODS METHODS
We genotyped four single nucleotide polymorphisms (SNPs) rs10841856, rs10770847, rs10770855 and rs4480590 in the CLEC4E gene using the improved multiplex ligation detection reaction (iMLDR) assay in 900 TB cases and 1534 healthy controls.
RESULTS RESULTS
After stratifying the whole data by sex, it was found that males exhibited mutant allele G of rs10841856 was more strongly associated with increased TB risk after Bonferroni correction (OR = 1.334, 95% CI: 1.142-1.560; P < 0.001 after adjusting for age; p = 0.001 after Bonferroni correction). The genetic model analysis found that rs10841856 was associated with the increased risk of TB among males under the dominant model (OR = 1.557, 95% CI = 1.228-1.984, P < 0.001 after adjusting for age, P < 0.001 after Bonferroni correction). Bioinformatics analysis suggested that rs10841856 might fall in putative functional regions and might be the expression quantitative trait loci (eQTL) for CLEC4E and long noncoding RNA RP11-561P12.5.
CONCLUSIONS CONCLUSIONS
Our study revealed that rs10841856 in the CLEC4E gene might be related to increased TB risk, especially the dominant genetic model among male Han individuals from Western China.

Identifiants

pubmed: 34376176
doi: 10.1186/s12879-021-06448-2
pii: 10.1186/s12879-021-06448-2
pmc: PMC8353747
doi:

Substances chimiques

CLEC4D protein, human 0
Lectins, C-Type 0
Receptors, Immunologic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

788

Subventions

Organisme : national natural science foundation of china
ID : 81472026
Organisme : science and technology project of tibet autonomous region
ID : XZ201901-GB-08

Informations de copyright

© 2021. The Author(s).

Références

Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
J Biosci. 2015 Sep;40(3):521-30
pubmed: 26333398
PLoS Pathog. 2008 Mar 28;4(3):e1000034
pubmed: 18369480
Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Clin Transl Immunology. 2018 Apr 18;7(4):e1017
pubmed: 29713472
Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4
pubmed: 22064851
PLoS Pathog. 2016 Dec 6;12(12):e1006038
pubmed: 27923071
Int Immunol. 2018 May 24;30(6):233-239
pubmed: 29726997
Lung. 2016 Oct;194(5):763-7
pubmed: 27363694
J Exp Med. 2009 Dec 21;206(13):2865-8
pubmed: 20008525
Genomics Inform. 2015 Dec;13(4):112-8
pubmed: 26865841
PLoS One. 2014 Sep 10;9(9):e107467
pubmed: 25208211
Front Immunol. 2014 Jun 23;5:288
pubmed: 25002863
Nat Rev Immunol. 2011 May;11(5):343-54
pubmed: 21475309
Mol Ther. 2017 Feb 1;25(2):307-309
pubmed: 28109956
Future Microbiol. 2013 Jul;8(7):839-54
pubmed: 23841632
Gene. 2018 May 20;655:35-41
pubmed: 29477867
Neurobiol Aging. 2013 May;34(5):1519.e13-7
pubmed: 23116876
Mol Immunol. 2017 Jul;87:240-248
pubmed: 28514713
Philos Trans R Soc Lond B Biol Sci. 2012 Mar 19;367(1590):850-9
pubmed: 22312052
Insect Biochem Mol Biol. 2015 Aug;63:1-6
pubmed: 25982022
Clin Infect Dis. 2017 Jan 15;64(2):111-115
pubmed: 28052967
DNA Cell Biol. 2020 Jan;39(1):57-62
pubmed: 31794672
Front Genet. 2019 Jan 18;9:678
pubmed: 30713548
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
J Infect Dis. 2014 Feb 15;209(4):578-87
pubmed: 24041785
Biopreserv Biobank. 2015 Oct;13(5):311-9
pubmed: 26484571
Nucleic Acids Res. 2018 Jan 4;46(D1):D276-D280
pubmed: 29077939
Infect Genet Evol. 2019 Nov;75:103950
pubmed: 31279003
Autophagy. 2020 Jun;16(6):1021-1043
pubmed: 31462144
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Gene. 2019 Aug 20;710:24-29
pubmed: 31075410
J Exp Med. 2009 Dec 21;206(13):2879-88
pubmed: 20008526
Medicine (Baltimore). 2015 Jun;94(24):e982
pubmed: 26091473
Curr Genet Med Rep. 2017 Sep;5(3):125-131
pubmed: 29201558
J Infect Dis. 2014 Jun 1;209(11):1837-46
pubmed: 24353272
Cytokine. 2019 Feb;114:11-17
pubmed: 30580155

Auteurs

Wenjing Zhou (W)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Lijuan Wu (L)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Jiajia Song (J)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Lin Jiao (L)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Yi Zhou (Y)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Juan Zhou (J)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Nian Wang (N)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Tangyuheng Liu (T)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Zhenzhen Zhao (Z)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Hao Bai (H)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Tao Wu (T)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Binwu Ying (B)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China. docbwy@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH